Search filters

List of works by Barbara Bryant

An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition

scientific article

Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma ⬇️

scientific article published on December 6, 2011

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma

scientific article published on 05 January 2016

Chromatin Computation ⬇️

scientific article published on May 2, 2012

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma.

scientific article published on 14 July 2016

EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation.

scientific article

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

scientific article

High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone.

scientific article published on January 2008

Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling

article

Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes.

scientific article published on 2 February 2016

Potential biomarkers of bortezomib activity in mantle cell lymphoma from the phase 2 PINNACLE trial.

scientific article published on July 2010

Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response.

scientific article published on 12 January 2016

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

scientific article

Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.

scientific article published on 11 May 2016

Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition

scientific article

Survival of genetic subtypes of relapsed myeloma may be modulated by secondary events

scientific article published on 01 April 2007

Targeting MYC dependence in cancer by inhibiting BET bromodomains

scientific article (publication date: 4 October 2011)

The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition

scientific article published on 15 November 2007

Paulina is supported by:

About Paulina

Help